FDA inspection
Akeso Biopharma, Co., Ltd.: FDA inspection ending Aug 7, 2023
FDA inspection 1218071 · Official Action Indicated (OAI) · Zhongshan
Key facts
| Inspection ID | 1218071 |
|---|---|
| Firm | Akeso Biopharma, Co., Ltd. |
| FEI number | 3017057933 |
| Address | 6 Shennong Road, Torch Development Zone |
| City | Zhongshan |
| Fiscal year | 2023 |
| Inspection end date | Aug 7, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data